Allavena, P <br/><br/>
Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.  [electronic resource] 

 -  Cancer research  Nov 1990 
 - 7318-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ascites<br/>Carcinoma--immunology<br/>Cytokines--biosynthesis<br/>Cytotoxicity, Immunologic<br/>Female<br/>HLA-D Antigens--metabolism<br/>Histocompatibility Antigens Class I--metabolism<br/>Humans<br/>Immunity, Cellular<br/>Injections, Intraperitoneal<br/>Interferon-gamma--administration & dosage<br/>Ovarian Neoplasms--immunology<br/>Recombinant Proteins